Parecoxib Sodium
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Post-Operative Pain
Conditions
Post-Operative Pain
Trial Timeline
Nov 1, 2010 → Sep 1, 2011
NCT ID
NCT01186159About Parecoxib Sodium
Parecoxib Sodium is a approved stage product being developed by Pfizer for Post-Operative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT01186159. Target conditions include Post-Operative Pain.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00435747 | Approved | Withdrawn |
| NCT01186159 | Approved | Completed |
Competing Products
18 competing products in Post-Operative Pain